Ansa Biotechnologies Raises $9.2 Million in Combined Seed and Pre-Seed Financing

BERKELEY, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies today announced that it has raised $7.9 million in an oversubscribed Seed round of funding led by Horizons Ventures, with participation from Mubadala Capital, Humboldt Fund, and additional investors. Combined with a Pre-Seed round raised in December 2018 led by Fifty Years, the company has raised $9.2 million to date. The new investment will accelerate the development of Ansa’s next-generation DNA synthesis technology. Ansa will use the fu

Click to view original post